The French Technical Vaccination Committee (CTV)
نویسندگان
چکیده
منابع مشابه
The French Technical Vaccination Committee (CTV).
This article describes the make-up and activities of the Technical Vaccination Committee (CTV) that serves as the National Immunization Technical Advisory Group (NITAG) in France. Comprised of a variety of technical experts, the CTV makes recommendations concerning vaccination. The committee functions as an independent expert advisory committee, and its proceedings are confidential, although it...
متن کاملReport of the Vaccination Committee
The Committee* appointed by the Society beg to present their Report on the evidence which the present state of medical knowledge supplies as to the conditions affecting the protection afforded by vaccination against death-f* by small-pox occurring in persons contracting that disease. In the first instance they desire to cordially thank those medical men who have assisted them to obtain the info...
متن کاملInternational Glutamate Technical Committee
While sodium reduction in the diet is an important objective, when salt (NaCl) levels are reduced in foods, its palatability is also generally decreased. Monosodium glutamate (MSG) is a flavour enhancer that contains about 12% sodium, which is less than half of that contained in regular table salt at about 39%. Therefore, by the addition of an appropriate amount of MSG, the palatability of low ...
متن کاملMessage from the technical program committee chair
The goal of the conference is to present significant research contributions to the field of network protocols. A lot of high-quality papers were submitted to ICNP. This year, totally we received 232 submissions from 24 countries all over the world. Each submission was assigned to three program committee members. The program committee members also met in Chicago to further discuss and make final...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Vaccine
سال: 2010
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2010.02.032